Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2284-2289

  Khan, Anis A ^a,b   Nasr, Mohamed ^c   Araujo, Fausto G ^a  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; ATOVAQUONE; CLINDAMYCIN; PYRIMETHAMINE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0031684764     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2284     Document Type: Article

References (14)

1. Araujo, F. G., J. Huskinson, and J. S. Remington. 1991. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35:293-299.
2. Araujo, F. G., J. Huskinson-Mark, W. E. Gutteridge, and J. S. Remington. 1992. In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrob. Agents Chemother. 36:326-330.
3. Araujo, F. G., A. A. Khan, and J. S. Remington. 1996. Rifapentine is active in vitro and in vivo against Toxoplasma gondii. Antimicrob. Agents Chemother. 40:1335-1337.
4. Araujo, F. G., T. Lin, and J. S. Remington. 1993. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine. J. Infect. Dis. 167:494-497.
5. Araujo, F. G., and J. S. Remington. 1992. Recent advances in the search for new drugs for treatment of toxoplasmosis. Int. J. Antimicrob. Agents 1:153-164.
6. Araujo, F. G., T. Slifer, and J. S. Remington. 1994. Rifabutin is active in models of murine toxoplasmosis. Antimicrob. Agents Chemother. 38:570-575.
7. Beaman, M. H., R. E. McCabe, S.-Y. Wong, and J. S. Remington. 1995. Toxoplasma gondii, p. 2455-2487. In G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, Inc., New York, N.Y.
8. Hudson, A. T., M. J. Pether, and A. W. Randall. 1986. In vitro activity of 2-cycloalkyl-3-hydroxy-1,4-naphthoquinones against Theileria, Eimeria and Plasmodia species. Eur. J. Med. Chem.-Chim. Ther. 21:271-275.
9. Hudson, A. T., A. W. Randall, M. Fry, C. D. Ginger, B. Hill, V. S. Latter, N. McHardy, and R. B. Williams. 1985. Novel anti-malarial hydroxynaphthoquinones with potent broad-spectrum anti-protozoal activity. Parasitology 90:45-55.
10. Khan, A. A., T. Slifer, F. G. Araujo, R. J. Polzer, and J. S. Remington. 1997. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Antimicrob. Agents Chemother. 41:893-897.
11. Khan, A. A., T. Slifer, F. G. Araujo, and J. S. Remington. 1996. Trovafloxacin is active against Toxoplasma gondii. Antimicrob. Agents Chemother. 40: 1855-1859.
12. Kovacs, J. A. 1992. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 340:637-638.
13. Wong, S.-Y., D. M. Israelski, and J. S. Remington. 1994 AIDS associated toxoplasmosis, p. 460-493. In M. A. Sande and P. Volberding (ed.), The medical management of AIDS, 4th ed. The W. B. Saunders Co., Philadelphia, Pa.
14. Wong, S.-Y., and J. S. Remington. 1994. Toxoplasmosis in the setting of AIDS, p. 223-257. In S. Broder, T. C. Merigan, and D. Bolognesi (ed.), Textbook of AIDS medicine. The Williams & Wilkins Co., Baltimore, Md.